These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14408393)

  • 1. Mineralocorticoid effects of 9 alpha-fluorodeoxycorticosterone in adrenalectomized rats.
    KAGAWA CM; JACOBS RS
    Proc Soc Exp Biol Med; 1960 May; 104():60-2. PubMed ID: 14408393
    [No Abstract]   [Full Text] [Related]  

  • 2. Life maintenance and mineralocorticoid activity of some new derivatives of cortisone, hydrocortisone and DOC.
    BAKER C; BRANNICK LJ; LEBRIE S; PARLOW AF; SWINGLE WW
    Endocrinology; 1956 Aug; 59(2):226-32. PubMed ID: 13356789
    [No Abstract]   [Full Text] [Related]  

  • 3. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension with mineralocorticoid administration to the Long-Evans rat.
    Holland OB; Gomez-Sanchez C; Ziegler T
    Clin Sci (Lond); 1979 Feb; 56(2):109-13. PubMed ID: 477192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 6-dehydro-DOCA and 6-dehydro-9 alpha-fluorocortisol acetate on the excretion of sodium and potassium in the rat.
    Genard P; Palem-Vliers M
    J Steroid Biochem; 1985 Nov; 23(5A):673-5. PubMed ID: 4079383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mineralocorticoid agonists and antagonists on binding of 3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
    Forte LR
    Life Sci I; 1972 May; 11(10):461-73. PubMed ID: 4348285
    [No Abstract]   [Full Text] [Related]  

  • 7. Azolimine: a nonsteroidal antagonist of the effects of mineralocorticoids on renal electrolyte excretion.
    Gussin RZ; Ronsberg MA; Stokey EH; Cummings JR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):8-15. PubMed ID: 1181406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
    Ehrlich EN; Lindheimer MD
    J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid and glucocorticoid effects on 31,000- and 29,000-dalton proopiomelanocortin in rat anterior pituitary and neurointermediate lobe.
    Khalid BA; Lim AT; Fraillon DR; Funder JW
    J Clin Invest; 1982 Aug; 70(2):443-52. PubMed ID: 6284802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the nephrosclerotic action of 2-methyl-9-fluorocortisol, a highly active artificial mineralocorticoid.
    BOIS P; SELYE H
    Endocrinology; 1956 Dec; 59(6):646-55. PubMed ID: 13375590
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of mineralocorticoids and glucocorticoids on compensatory adrenal growth in rats.
    Phillips R; Crock C; Funder J
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E450-6. PubMed ID: 3985143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
    Sekihara H; Island DP; Liddle GW
    Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid activity of 19-nor-DOC and 19-OH-DOC in adrenalectomized rat.
    Perrone RD; Bengele HH; Dale SL; Melby JC; Alexander EA
    Am J Physiol; 1982 May; 242(5):E305-8. PubMed ID: 7081431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthetic mineralocorticoid].
    Miyamori I
    Nihon Rinsho; 2008 Jan; 66(1):125-9. PubMed ID: 18193551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
    Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of desoxycorticosterone and methylfluorocortisol on the vascular response to adrenaline].
    PANISSET JC; BOIS P; BEAULNES A
    Rev Can Biol; 1961 Apr; 20():71-3. PubMed ID: 13732465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and long-term follow-up of 205 dogs with hypoadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1997; 11(2):43-9. PubMed ID: 9127289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muscular lesions (and visceral) in rats during mineralocorticoid poisoning].
    REMELLI L
    Riv Anat Patol Oncol; 1955 Jun; 9(9):1183-206. PubMed ID: 13273867
    [No Abstract]   [Full Text] [Related]  

  • 20. The adrenal cortex and hypertension: some observations on a possible role for mineralocorticoids other than aldosterone.
    Fraser R; Brown JJ; Brown WC; Ferriss JB; Kennedy A; Lever AF; Mason PA; Morton JJ; Nicholls MG; Ramsay LE; Robertson JI; Schalekamp MA; Wilson A
    J Steroid Biochem; 1976; 7(11-12):963-70. PubMed ID: 192947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.